NasdaqGS - Delayed Quote USD

Guardant Health, Inc. (GH)

19.44 +0.80 (+4.29%)
At close: May 9 at 4:00 PM EDT
21.78 +2.34 (+12.04%)
After hours: May 9 at 7:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
563,948.00
563,948.00
449,538.00
373,653.00
286,730.00
Cost of Revenue
227,052.00
227,052.00
156,325.00
122,912.00
92,535.00
Gross Profit
336,896.00
336,896.00
293,213.00
250,741.00
194,195.00
Operating Expense
901,621.00
901,621.00
837,591.00
661,742.00
449,145.00
Operating Income
-564,725.00
-564,725.00
-544,378.00
-411,001.00
-254,950.00
Net Non Operating Interest Income Expense
32,787.00
32,787.00
3,492.00
1,353.00
5,405.00
Other Income Expense
53,174.00
53,174.00
-112,563.00
25,178.00
3,641.00
Pretax Income
-478,764.00
-478,764.00
-653,449.00
-384,470.00
-245,904.00
Tax Provision
685.00
685.00
1,139.00
300.00
379.00
Net Income Common Stockholders
-479,449.00
-479,449.00
-654,588.00
-405,670.00
-253,783.00
Diluted NI Available to Com Stockholders
-479,449.00
-479,449.00
-654,588.00
-405,670.00
-253,783.00
Basic EPS
-4.03
-4.28
-6.41
-4.00
-2.60
Diluted EPS
-4.03
-4.28
-6.41
-4.00
-2.60
Basic Average Shares
107,972.50
111,988.00
102,178.00
101,314.00
97,504.00
Diluted Average Shares
107,972.50
111,988.00
102,178.00
101,314.00
97,504.00
Total Operating Income as Reported
-564,725.00
-564,725.00
-544,378.00
-411,001.00
-254,950.00
Total Expenses
1,128,673.00
1,128,673.00
993,916.00
784,654.00
541,680.00
Net Income from Continuing & Discontinued Operation
-479,449.00
-479,449.00
-654,588.00
-405,670.00
-253,783.00
Normalized Income
-479,449.00
-479,449.00
-654,588.00
-405,670.00
-253,783.00
Interest Income
35,365.00
35,365.00
6,069.00
3,930.00
10,171.00
Interest Expense
2,578.00
2,578.00
2,577.00
2,577.00
4,766.00
Net Interest Income
32,787.00
32,787.00
3,492.00
1,353.00
5,405.00
EBIT
-476,186.00
-476,186.00
-650,872.00
-381,893.00
-241,138.00
EBITDA
-433,305.00
-433,305.00
-614,910.00
-359,622.00
-225,073.00
Reconciled Cost of Revenue
227,052.00
227,052.00
156,325.00
122,912.00
92,535.00
Reconciled Depreciation
42,881.00
42,881.00
35,962.00
22,271.00
16,065.00
Net Income from Continuing Operation Net Minority Interest
-479,449.00
-479,449.00
-654,588.00
-405,670.00
-253,783.00
Normalized EBITDA
-433,305.00
-433,305.00
-614,910.00
-359,622.00
-225,073.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 10/4/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EXAS Exact Sciences Corporation
54.15
-8.96%
 
NTRA Natera, Inc.
95.55
-0.11%
 
ILMN Illumina, Inc.
111.35
+0.66%
 
TWST Twist Bioscience Corporation
43.20
+4.35%
 
CDNA CareDx, Inc
11.06
+8.64%
 
MYGN Myriad Genetics, Inc.
25.25
+5.43%
 
PSNL Personalis, Inc.
1.6500
+5.43%
 
FLGT Fulgent Genetics, Inc.
21.79
+2.44%
 
VCYT Veracyte, Inc.
20.63
+2.53%
 
NEO NeoGenomics, Inc.
15.50
+2.45%